Both New and Chronic Potentially Inappropriate Medications Continued at Hospital Discharge Are Associated With Increased Risk of Adverse Events
Daniala L. Weir(McGill University Health Centre), Robyn Tamblyn(McGill University), Emily G. McDonald(McGill University), Aude Motulsky(Centre Hospitalier de l’Université de Montréal), Todd C. Lee(McGill University Health Centre), Steven G. Morgan(University of British Columbia), Michał Abrahamowicz(Centre Hospitalier de l’Université de Montréal), David L. Buckeridge(McGill University)
Cited by 78
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Predatory journals: no definition, no defence
|Nature|2019|716
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
|The Lancet Infectious Diseases|2023|658
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
|Annals of Internal Medicine|2020|548
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2
|JAMA Internal Medicine|2021|327